Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Mitochondrial mass assessed by NAO staining in ( a ) HCT116 cells treated with TS-targeting therapies, ( b ) non-small cell lung cancer (NSCLC) cell lines treated with pemetrexed, ( c ) HCT116 cells treated with 5FU, FOLFOX (5FU+oxaliplatin), FOLFIRI (5FU + SN38), or single agent oxaliplatin and SN38, or ( d ) HCT116 cells treated 5FU Torin or rapamycin for 72 h
Gi cho ln da mm mi, mn mng v trn y sc sng
Do khng t thay i liu dng hoc ngng dng m cha thng qua kin ca bc s
Transparency regarding sourcing and formulation is vital, as is checking for third-party testing
US$ 26.44
US$ 27.30
US$ 21.31
US$ 23.34
US$ 28.03
US$ 27.66
US$ 22.40
